Win Advisors’s Cardinal Health CAH Stock Holding History

Win Advisors’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-162	Closed	-$9K	–	126
2022 Q2	$9K	Buy	162 +119	+277%	+$6.76K	0.02%	117
2022 Q1	$2K	Buy	+43	New	+$2.3K	﹤0.01%	182

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Win Advisors's CAH Position: Q3 2022 in Review

Win Advisors sold out of Cardinal Health (CAH) in Q3 2022, closing a stake of 162 shares — an estimated $9K sold.

Win Advisors first reported a position in CAH in Q1 2022 and held it in 2 quarters. The position peaked at $9K in Q2 2022. 849 funds tracked by Wall St. Rank hold CAH as of Q3 2022.

Win Advisors reported no remaining Cardinal Health position as of Q3 2022 after selling out during the quarter.
Win Advisors sold 162 Cardinal Health shares in Q3 2022, an estimated $9K.
Win Advisors first reported a position in Cardinal Health in Q1 2022 and held it in 2 quarters.
Win Advisors's Cardinal Health position peaked at $9K in Q2 2022.
849 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2022.

Based on Win Advisors's 13F filing for Q3 2022, filed 27 Oct 2022.